Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065

被引：14
|
作者：
Boger, DL
Stauffer, F
Hedrick, MP
机构：
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/S0960-894X(01)00372-9
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of CBI analogues of the duocarmycins and CC-1065 exploring substituent effects within the first indole DNA binding subunit are detailed. Substitution at the indole C5 position led to cytotoxic potency enhancements that are greater than or equal to 1000-fold, providing simplified analogues containing a single DNA binding subunit that are more potent (IC50 = 2-3 pM) than CBI-TMI, duocarmycin SA, or CC-1065. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：2021 / 2024
页数：4
相关论文
共 50 条
  • [1] Establishment of substituent effects in the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065
    Parrish, JP
    Kastrinsky, DB
    Stauffer, F
    Hedrick, MP
    Hwang, I
    Boger, DL
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (17) : 3815 - 3838
  • [2] CBI prodrug analogs of CC-1065 and the duocarmycins
    Boger, DL
    Boyce, CW
    Garbaccio, RM
    Searcey, M
    Jin, Q
    SYNTHESIS-STUTTGART, 1999, : 1505 - 1509
  • [3] Synthesis and evaluation of a series of C3-substituted CBI analogues of CC-1065 and the duocarmycins
    Boger, DL
    Brunette, SR
    Garbaccio, RM
    JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (15): : 5163 - 5173
  • [4] CC-1065 and the duocarmycins: recent developments
    Cacciari, B
    Romagnoli, R
    Baraldi, PG
    Da Ros, T
    Spalluto, G
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (12) : 1853 - 1871
  • [5] THE SYNTHESIS OF SUBSTITUTED CBI ANALOGS OF CC-1065 AND THE DUOCARMYCINS - 7-CYANO-CBI(CCBI)
    TARBY, CM
    MCKIE, JA
    BOGER, DL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 205 - ORGN
  • [6] Novel Analogues of CC-1065 and the Duocarmycins for the Use in Targeted Tumour Therapies
    Tietze, Lutz F.
    Krewer, Birgit
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (03) : 304 - 325
  • [7] CC-1065 and the duocarmycins: Synthetic studies
    Boger, DL
    Boyce, CW
    Garbaccio, RM
    Goldberg, JA
    CHEMICAL REVIEWS, 1997, 97 (03) : 787 - 828
  • [8] Rational design, synthesis, and evaluation of key analogues of CC-1065 and the duocarmycins
    Tichenor, Mark S.
    MacMillan, Karen S.
    Stover, James S.
    Wolkenberg, Scott E.
    Pavani, Maria G.
    Zanella, Lorenzo
    Zaid, Abdel N.
    Spalluto, Gianpiero
    Rayl, Thomas J.
    Hwang, Inkyu
    Baraldi, Pier Giovanni
    Boger, Dale L.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (45) : 14092 - 14099
  • [9] CC-1065 and the duocarmycins: Mechanistic studies.
    Boger, DL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U29 - U29
  • [10] Mechanism of DNA binding of duocarmycins and CC1065
    不详
    DRUG DISCOVERY TODAY, 1997, 2 (07) : 304 - 304
12345